Citable filing context

PM filing events and research context

Server-rendered

PM's research view summarizes recent SEC filing context, starting with management_change from May 20, 2026.

PM filing events and research context
FiledItemContext
May 20, 2026management_changeReports changes in directors/officers and their compensatory arrangements.
May 8, 2026management_changePhilip Morris International shareholders elected directors at the Annual Meeting on May 6, 2026.
Apr 29, 2026debt_offeringPhilip Morris International issued $1.5 billion in 4.125% Notes due 2029 and 4.875% Notes due 2036.
Apr 22, 2026Guidance: adjusted_diluted_eps2.02 to 2.07
Apr 22, 2026Guidance: adjusted_diluted_eps8.36 to 8.51
Apr 22, 2026Guidance: adjusted_diluted_eps_ex_currency8.11 to 8.26
Apr 24, 2026mda_quarterlyDuring the quarter ended March 31, 2026, PM repurchased a total of 270,470 shares at an average price of $181.88 per share. These repurchases were not part of a publicly announced buyback program but instead represented shares tendered by employees to satisfy tax obligations upon the vesting of restricted and performance share unit awards. No directors or officers initiated or terminated any Rule 10b5-1 or non-Rule 10b5-1 trading arrangements during this period, indicating no new pre-planned insider stock transactions. Significant executive compensation adjustments were noted. Effective November 1, 2025, Massimo Andolina's annual base salary increased by 5.9% to CHF 900,003. Concurrently, his target incentive compensation rose from 100% to 125% of base salary, and his target stock award eligibility increased from 175% to 275% of base salary. Additionally, CEO Jacek Olczak received a 6.67% increase in his annual base salary, effective February 1, 2026, bringing it to CHF 1,600,000. The filing also included the standard Sarbanes-Oxley certifications from both the CEO and CFO, attesting to the accuracy of the financial information and the efficacy of internal controls.
Feb 6, 2026businessPhilip Morris International (PMI) is a leading global consumer goods company actively transforming towards a "smoke-free future," aiming to eventually cease cigarette sales. Its core business comprises traditional cigarettes, led by Marlboro (43% of 2025 cigarette shipment volume), and a rapidly expanding portfolio of smoke-free products (SFPs). PMI has invested over $16 billion since 2008 in SFPs, including heat-not-burn (IQOS, with brands like HEETS and TEREA), nicotine pouches (ZYN), and e-vapor products. Key strategic developments include the November 2022 acquisition of Swedish Match, significantly bolstering its oral nicotine presence with ZYN, and securing full U.S. commercial rights for IQOS in April 2024. The U.S. FDA has authorized marketing and granted Modified Risk Tobacco Product (MRTP) designations for IQOS, ZYN, and General snus. PMI also has a long-term ambition to expand into wellness through its Aspeya unit, focusing on oral consumer wellness and non-recreational cannabinoid products. The company operates in approximately 170 cigarette markets and 106 SFP markets, facing intense competition from major tobacco companies and new entrants. Effective January 2026, PMI reorganized into International Smoke-Free, International Combustibles, and U.S. segments, reflecting its strategic shift.

Source: SEC EDGAR filing text and events; period May 20, 2026; filed May 20, 2026.

Continue research

Follow same-sector companies and source explainers connected to the research view.